{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T19:23:49Z","timestamp":1774293829879,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1475-2840-13-51","type":"journal-article","created":{"date-parts":[[2014,2,24]],"date-time":"2014-02-24T15:41:15Z","timestamp":1393256475000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Reduced circulating sTWEAK levels are associated with metabolic syndrome in elderly individuals at high cardiovascular risk"],"prefix":"10.1186","volume":"13","author":[{"given":"Andr\u00e9s","family":"D\u00edaz-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f2nica","family":"Bull\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matilde R","family":"Chac\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram\u00f3n","family":"Estruch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Vendrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"D\u00edez-Espino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Fit\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolores","family":"Corella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Salas-Salvad\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,24]]},"reference":[{"issue":"51","key":"810_CR1","doi-asserted-by":"publisher","first-page":"32401","DOI":"10.1074\/jbc.272.51.32401","volume":"272","author":"Y Chicheportiche","year":"1997","unstructured":"Chicheportiche Y, Bourdon PR, Xu H, Hsu YM, Scott H, Hession C, Garcia I, Browning JL: TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem. 1997, 272 (51): 32401-32410. 10.1074\/jbc.272.51.32401.","journal-title":"J Biol Chem"},{"key":"810_CR2","volume-title":"Mediators Inflamm","author":"MD Sanchez-Ni\u00f1o","year":"2010","unstructured":"Sanchez-Ni\u00f1o MD, Benito-Martin A, Gon\u00e7alves S, Sanz AB, Ucero AC, Izquierdo MC, Ramos AM, Berzal S, Selgas R, Ruiz-Ortega M, Egido J, Ortiz A: TNF superfamily: a growing saga of kidney injury modulators. Mediators Inflamm. 2010, doi:10.1155\/2010\/182958"},{"issue":"3\u20134","key":"810_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1359-6101(03)00019-4","volume":"14","author":"SR Wiley","year":"2003","unstructured":"Wiley SR, Winkles JA: TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR\/Fn14 receptor. Cytokine Growth Factor Rev. 2003, 14 (3\u20134): 241-249.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"5","key":"810_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrd2488","volume":"7","author":"JA Winkles","year":"2008","unstructured":"Winkles JA: The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting. Nat Rev Drug Discov. 2008, 7 (5): 411-425. 10.1038\/nrd2488.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"810_CR5","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1161\/01.ATV.0000258972.10109.ff","volume":"27","author":"LM Blanco-Colio","year":"2007","unstructured":"Blanco-Colio LM, Martin-Ventura JL, Munoz-Garcia B, Orbe J, Paramo JA, Michel JB, Ortiz A, Meilhac O, Egido J: Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis. Arterioscler Thromb Vasc Biol. 2007, 27 (4): 916-922. 10.1161\/01.ATV.0000258972.10109.ff.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"810_CR6","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1093\/eurjhf\/hfp139","volume":"11","author":"E Chorianopoulos","year":"2009","unstructured":"Chorianopoulos E, Rosenberg M, Zugck C, Wolf J, Katus HA, Frey N: Decreased soluble TWEAK levels predict an adverse prognosis in patients with chronic stable heart failure. Eur J Heart Fail. 2009, 11 (11): 1050-1056. 10.1093\/eurjhf\/hfp139.","journal-title":"Eur J Heart Fail"},{"issue":"13\u201314","key":"810_CR7","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.clinbiochem.2009.06.001","volume":"42","author":"Z Jelic-Ivanovic","year":"2009","unstructured":"Jelic-Ivanovic Z, Bujisic N, Spasic S, Bogavac-Stanojevic N, Spasojevic-Kalimanovska V, Kotur-Stevuljevic J: Circulating sTWEAK improves the prediction of coronary artery disease. Clin Biochem. 2009, 42 (13\u201314): 1381-1386.","journal-title":"Clin Biochem"},{"issue":"1","key":"810_CR8","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.atherosclerosis.2010.02.016","volume":"211","author":"E Chorianopoulos","year":"2010","unstructured":"Chorianopoulos E, Jarr K, Steen H, Giannitsis E, Frey N, Katus HA: Soluble TWEAK is markedly upregulated in patients with ST-elevation myocardial infarction and related to an adverse short-term outcome. Atherosclerosis. 2010, 211 (1): 322-326. 10.1016\/j.atherosclerosis.2010.02.016.","journal-title":"Atherosclerosis"},{"issue":"6","key":"810_CR9","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1161\/ATVBAHA.110.203364","volume":"30","author":"JA Moreno","year":"2010","unstructured":"Moreno JA, Dejouvencel T, Labreuche J, Smadja DM, Dussiot M, Martin-Ventura JL, Egido J, Gaussem P, Emmerich J, Michel JB, Blanco-Colio LM, Meilhac O: Peripheral artery disease is associated with a high CD163\/TWEAK plasma ratio. Arterioscler Thromb Vasc Biol. 2010, 30 (6): 1253-1262. 10.1161\/ATVBAHA.110.203364.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"810_CR10","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.atherosclerosis.2007.10.022","volume":"199","author":"S Kralisch","year":"2008","unstructured":"Kralisch S, Ziegelmeier M, Bachmann A, Seeger J, Lossner U, Bluher M, Stumvoll M, Fasshauer M: Serum levels of the atherosclerosis biomarker sTWEAK are decreased in type 2 diabetes and end-stage renal disease. Atherosclerosis. 2008, 199 (2): 440-444. 10.1016\/j.atherosclerosis.2007.10.022.","journal-title":"Atherosclerosis"},{"issue":"1","key":"810_CR11","doi-asserted-by":"crossref","first-page":"E20","DOI":"10.25011\/cim.v35i1.16102","volume":"35","author":"N Karadurmus","year":"2012","unstructured":"Karadurmus N, Tapan S, Cakar M, Naharci I, Celik T, Tasci I, Sayin S, Dogan T, Turker T, Erbil MK, Saglam K: Lower plasma soluble TWEAK concentration in patients with newly diagnosed hypertension. Clin Invest Med. 2012, 35 (1): E20-E26.","journal-title":"Clin Invest Med"},{"issue":"11","key":"810_CR12","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.2215\/CJN.02760409","volume":"4","author":"MI Yilmaz","year":"2009","unstructured":"Yilmaz MI, Carrero JJ, Ortiz A, Martin-Ventura JL, Sonmez A, Saglam M, Yaman H, Yenicesu M, Egido J, Blanco-Colio LM: Soluble TWEAK plasma levels as a novel biomarker of endothelial function in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2009, 4 (11): 1716-1723. 10.2215\/CJN.02760409.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"810_CR13","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.atherosclerosis.2011.09.016","volume":"219","author":"G Urbonaviciene","year":"2011","unstructured":"Urbonaviciene G, Martin-Ventura JL, Lindholt JS, Urbonavicius S, Moreno JA, Egido J, Blanco-Colio LM: Impact of soluble TWEAK and CD163\/TWEAK ratio on long-term cardiovascular mortality in patients with peripheral arterial disease. Atherosclerosis. 2011, 219 (2): 892-899. 10.1016\/j.atherosclerosis.2011.09.016.","journal-title":"Atherosclerosis"},{"issue":"1","key":"810_CR14","first-page":"27","volume":"5","author":"SB Hassan","year":"2012","unstructured":"Hassan SB, El-demery AB, Ahmed AI, Abukhalil RE: Soluble TWEAK and cardiovascular morbidity and mortality in chronic kidney disease patients. Arab J Nephrol Transplant. 2012, 5 (1): 27-32.","journal-title":"Arab J Nephrol Transplant"},{"issue":"8","key":"810_CR15","doi-asserted-by":"publisher","first-page":"e43919","DOI":"10.1371\/journal.pone.0043919","volume":"7","author":"G Llaurado","year":"2012","unstructured":"Llaurado G, Gonzalez-Clemente JM, Maymo-Masip E, Subias D, Vendrell J, Chacon MR: Serum Levels of TWEAK and Scavenger Receptor CD163 in Type 1 Diabetes Mellitus: Relationship with Cardiovascular Risk Factors. A case\u2013control Study. PLoS One. 2012, 7 (8): e43919-10.1371\/journal.pone.0043919.","journal-title":"PLoS One"},{"issue":"8","key":"810_CR16","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1210\/jc.2013-1848","volume":"98","author":"A Diaz-Lopez","year":"2013","unstructured":"Diaz-Lopez A, Maymo-Masip E, Bullo M, Chacon MR, Martinez-Gonzalez MA, Estruch R, Vendrell J, Basora J, Diez-Espino J, Covas MI, Salas-Salvado J: Serum sTWEAK concentrations and risk of developing type 2 diabetes in a high cardiovascular risk population: a nested case\u2013control study. J Clin Endocrinol Metab. 2013, 98 (8): 3482-3490. 10.1210\/jc.2013-1848.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"810_CR17","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1161\/01.CIR.0000158483.13093.9D","volume":"111","author":"P Dandona","year":"2005","unstructured":"Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R: Metabolic syndrome a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation. 2005, 111 (11): 1448-1454. 10.1161\/01.CIR.0000158483.13093.9D.","journal-title":"Circulation"},{"issue":"14","key":"810_CR18","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1056\/NEJMoa1200303","volume":"368","author":"R Estruch","year":"2013","unstructured":"Estruch R, Ros E, Salas-Salvad\u00f3 J, Covas MI, Corella D, Ar\u00f3s F, G\u00f3mez-Gracia E, Ruiz Guti\u00e9rrez V, Fiol M, Lapetra J, Lamuela-Raventos RM, Serra-Majem L, Pint\u00f3 X, Basora J, Mu\u00f1oz MA, Sorl\u00ed JV, Mart\u00ednez JA, Mart\u00ednez-Gonz\u00e1lez MA, PREDIMED Study Investigators: Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013, 368 (14): 1279-1290. 10.1056\/NEJMoa1200303.","journal-title":"N Engl J Med"},{"issue":"12","key":"810_CR19","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1017\/S0007114509993837","volume":"103","author":"JD Fernandez-Ballart","year":"2010","unstructured":"Fernandez-Ballart JD, Pinol JL, Zazpe I, Corella D, Carrasco P, Toledo E, Perez-Bauer M, Martinez-Gonzalez MA, Salas-Salvado J, Martin-Moreno JM: Relative validity of a semi-quantitative food-frequency questionnaire in an elderly Mediterranean population of Spain. Br J Nutr. 2010, 103 (12): 1808-1816. 10.1017\/S0007114509993837.","journal-title":"Br J Nutr"},{"issue":"12","key":"810_CR20","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/oxfordjournals.aje.a116966","volume":"139","author":"R Elosua","year":"1994","unstructured":"Elosua R, Marrugat J, Molina L, Pons S, Pujol E: Validation of the Minnesota leisure time physical activity questionnaire in Spanish men. The MARATHOM investigators. Am J Epidemiol. 1994, 139 (12): 1197-1209.","journal-title":"Am J Epidemiol"},{"issue":"19","key":"810_CR21","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0025-7753(03)74080-9","volume":"121","author":"J Redon","year":"2003","unstructured":"Redon J, Coca A: Guidelines for the diagnosis, evaluation and treatment of hypertension: the point of view of the Spanish Society of Hypertension. Med Clin (Barc). 2003, 121 (19): 739-740. 10.1016\/S0025-7753(03)74080-9.","journal-title":"Med Clin (Barc)"},{"issue":"9","key":"810_CR22","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009, 150 (9): 604-612. 10.7326\/0003-4819-150-9-200905050-00006.","journal-title":"Ann Intern Med"},{"issue":"16","key":"810_CR23","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"K Alberti","year":"2009","unstructured":"Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart J, James WPT, Loria CM, Smith SC: Harmonizing the metabolic syndrome a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009, 120 (16): 1640-1645. 10.1161\/CIRCULATIONAHA.109.192644.","journal-title":"Circulation"},{"issue":"4","key":"810_CR24","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jacc.2006.09.032","volume":"49","author":"AS Gami","year":"2007","unstructured":"Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM: Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007, 49 (4): 403-414. 10.1016\/j.jacc.2006.09.032.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"810_CR25","doi-asserted-by":"publisher","first-page":"785","DOI":"10.2215\/CJN.09231010","volume":"6","author":"MI Yilmaz","year":"2011","unstructured":"Yilmaz MI, Sonmez A, Ortiz A, Saglam M, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, \u00c7akar M: Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes. Clin J Am Soc Nephrol. 2011, 6 (4): 785-792. 10.2215\/CJN.09231010.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"810_CR26","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1210\/jc.2009-2481","volume":"95","author":"J Vendrell","year":"2010","unstructured":"Vendrell J, Maymo-Masip E, Tinahones F, Garcia-Espana A, Megia A, Caubet E, Garcia-Fuentes E, Chacon MR: Tumor necrosis-like weak inducer of apoptosis as a proinflammatory cytokine in human adipocyte cells: up-regulation in severe obesity is mediated by inflammation but not hypoxia. J Clin Endocrinol Metab. 2010, 95 (6): 2983-2992. 10.1210\/jc.2009-2481.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"810_CR27","doi-asserted-by":"publisher","first-page":"E1323","DOI":"10.1210\/jc.2012-4177","volume":"98","author":"E Maym\u00f3-Masip","year":"2013","unstructured":"Maym\u00f3-Masip E, Fern\u00e1ndez-Veledo S, Garc\u00eda-Espa\u00f1a A, V\u00e1zquez-Carballo A, Tinahones FJ, Garc\u00eda-Fuentes E, Garrido-Sanchez L, Rodr\u00edguez MM, Vendrell J, Chac\u00f3n MR: The rise of soluble TWEAK levels in severely obese subjects after bariatric surgery May affect adipocyte-cytokine production induced by TNF\u03b1. J Clin Endocrinol Metab. 2013, 98 (8): E1323-E1333. 10.1210\/jc.2012-4177.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"810_CR28","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.1210\/en.2009-0488","volume":"150","author":"G Tiller","year":"2009","unstructured":"Tiller G, Fischer-Posovszky P, Laumen H, Finck A, Skurk T, Keuper M, Brinkmann U, Wabitsch M, Link D, Hauner H: Effects of TWEAK (TNF superfamily member 12) on differentiation, metabolism, and secretory function of human primary preadipocytes and adipocytes. Endocrinology. 2009, 150 (12): 5373-5383. 10.1210\/en.2009-0488.","journal-title":"Endocrinology"},{"issue":"5","key":"810_CR29","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.cell.2005.09.022","volume":"123","author":"H Maecker","year":"2005","unstructured":"Maecker H, Varfolomeev E, Kischkel F, Lawrence D, LeBlanc H, Lee W, Hurst S, Danilenko D, Li J, Filvaroff E: TWEAK attenuates the transition from innate to adaptive immunity. Cell. 2005, 123 (5): 931-944. 10.1016\/j.cell.2005.09.022.","journal-title":"Cell"},{"issue":"6","key":"810_CR30","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1161\/01.CIR.0000028581.07992.56","volume":"106","author":"JA Vita","year":"2002","unstructured":"Vita JA, Keaney JF: Endothelial function a barometer for cardiovascular risk?. Circulation. 2002, 106 (6): 640-642. 10.1161\/01.CIR.0000028581.07992.56.","journal-title":"Circulation"},{"issue":"3","key":"810_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cyto.2005.12.005","volume":"33","author":"MR Chacon","year":"2006","unstructured":"Chacon MR, Richart C, Gomez JM, Megia A, Vilarrasa N, Fernandez-Real JM, Garcia-Espana A, Miranda M, Masdevall C, Ricard W, Caubet E, Soler J, Vendrell J: Expression of TWEAK and its receptor Fn14 in human subcutaneous adipose tissue. Relationship with other inflammatory cytokines in obesity. Cytokine. 2006, 33 (3): 129-137. 10.1016\/j.cyto.2005.12.005.","journal-title":"Cytokine"},{"issue":"12","key":"810_CR32","doi-asserted-by":"publisher","first-page":"8183","DOI":"10.4049\/jimmunol.178.12.8183","volume":"178","author":"LC Bover","year":"2007","unstructured":"Bover LC, Cardo-Vila M, Kuniyasu A, Sun J, Rangel R, Takeya M, Aggarwal BB, Arap W, Pasqualini R: A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications. J Immunol. 2007, 178 (12): 8183-8194.","journal-title":"J Immunol"},{"key":"810_CR33","volume-title":"Obesity","author":"K Fjeldborg","year":"2013","unstructured":"Fjeldborg K, Christiansen T, Bennetzen M, M\u00f8ller HJ, Pedersen SB, Richelsen B: The macrophage specific serum marker, soluble CD163, is increased in obesity and reduced after dietary induced weight loss. Obesity. 2013, doi:10.1002\/oby.20376. [Epub ahead of print]"},{"issue":"11","key":"810_CR34","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1111\/j.1365-2362.2012.02714.x","volume":"42","author":"NM Al-Daghri","year":"2012","unstructured":"Al-Daghri NM, Al-Attas OS, Bindahman LS, Alokail MS, Alkharfy KM, Draz HM, Yakout S, McTernan PG, Sabico S, Chrousos GP: Soluble CD163 is associated with body mass index and blood pressure in hypertensive obese Saudi patients. Eur J Clin Invest. 2012, 42 (11): 1221-1226. 10.1111\/j.1365-2362.2012.02714.x.","journal-title":"Eur J Clin Invest"},{"key":"810_CR35","first-page":"0","volume":"28","author":"JM Valdivielso","year":"2013","unstructured":"Valdivielso JM, Coll B, Mart\u00edn-Ventura JL, Moreno JA, Egido J, Fern\u00e1ndez E, Blanco-Colio LM: Soluble TWEAK is associated with atherosclerotic burden in patients with chronic kidney disease. J Nephrol. 2013, 28: 0-doi:10.5301\/jn.5000245. [Epub ahead of print]","journal-title":"J Nephrol"},{"issue":"14","key":"810_CR36","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1056\/NEJMoa050080","volume":"353","author":"A Tirosh","year":"2005","unstructured":"Tirosh A, Shai I, Tekes-Manova D, Israeli E, Pereg D, Shochat T, Kochba I, Rudich A: Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med. 2005, 353 (14): 1454-1462. 10.1056\/NEJMoa050080.","journal-title":"N Engl J Med"},{"issue":"4","key":"810_CR37","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1210\/en.2007-1119","volume":"149","author":"F Feng","year":"2008","unstructured":"Feng F, Wang L, Albanese N, Holmes A, Xia P: Tumor necrosis factor-like weak inducer of apoptosis attenuates the action of insulin in hepatocytes. Endocrinology. 2008, 149 (4): 1505-1513. 10.1210\/en.2007-1119.","journal-title":"Endocrinology"},{"key":"810_CR38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1475-2840-11-21","volume":"11","author":"CS Chu","year":"2012","unstructured":"Chu CS, Lee KT, Cheng KH, Lee MY, Kuo HF, Lin TH, Su HM, Voon WC, Sheu SH, Lai WT: Postchallenge responses of nitrotyrosine and TNF-alpha during 75-g oral glucose tolerance test are associated with the presence of coronary artery diseases in patients with prediabetes. Cardiovasc Diabetol. 2012, 11: 21-10.1186\/1475-2840-11-21.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"810_CR39","doi-asserted-by":"publisher","first-page":"E101","DOI":"10.1152\/ajpendo.00589.2012","volume":"305","author":"A Vazquez-Carballo","year":"2013","unstructured":"Vazquez-Carballo A, Ceperuelo-Mallafr\u00e9 V, Chacon MR, Maymo-Masip E, Lorenzo M, Porras A, Vendrell J, Fernandez-Veledo S: Tweak prevents TNF-\u03b1-induced insulin resistance through PP2A activation in human adipocytes. Am J Physiol Endocrinol Metab. 2013, 305 (1): E101-112. 10.1152\/ajpendo.00589.2012.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"810_CR40","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/1475-2840-11-100","volume":"11","author":"NM Leguisamo","year":"2012","unstructured":"Leguisamo NM, Lehnen AM, Machado UF, Okamoto MM, Markoski MM, Pinto GH, Schaan BD: GLUT4 content decreases along with insulin resistance and high levels of inflammatory markers in rats with metabolic syndrome. Cardiovasc Diabetol. 2012, 11: 100-10.1186\/1475-2840-11-100.","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"810_CR41","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1210\/jc.2009-0558","volume":"94","author":"S Fern\u00e1ndez-Veledo","year":"2009","unstructured":"Fern\u00e1ndez-Veledo S, Vila-Bedmar R, Nieto-Vazquez I, Lorenzo M: c-Jun N-terminal kinase 1\/2 activation by tumor necrosis factor-\u03b1 induces insulin resistance in human visceral but not subcutaneous adipocytes: reversal by liver X receptor agonists. J Clin Endocrinol Metab. 2009, 94 (9): 3583-3593. 10.1210\/jc.2009-0558.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"810_CR42","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.cellimm.2011.09.004","volume":"272","author":"J Yamana","year":"2012","unstructured":"Yamana J, Morand EF, Manabu T, Sunahori K, Takasugi K, Makino H, Yamamura M: Inhibition of TNF-induced IL-6 by the TWEAK-Fn14 interaction in rheumatoid arthritis fibroblast like synoviocytes. Cell Immunol. 2012, 272 (2): 293-298. 10.1016\/j.cellimm.2011.09.004.","journal-title":"Cell Immunol"},{"issue":"1","key":"810_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1742-2094-9-45","volume":"9","author":"R Echeverry","year":"2012","unstructured":"Echeverry R, Wu F, Haile WB, Wu J, Yepes M: The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous system. J Neuroinflammation. 2012, 9 (1): 45-10.1186\/1742-2094-9-45.","journal-title":"J Neuroinflammation"},{"issue":"11","key":"810_CR44","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/cdd.2009.80","volume":"16","author":"A Wicovsky","year":"2009","unstructured":"Wicovsky A, Salzmann S, Roos C, Ehrenschwender M, Rosenthal T, Siegmund D, Henkler F, Gohlke F, Kneitz C, Wajant H: TNF-like weak inducer of apoptosis inhibits proinflammatory TNF receptor-1 signaling. Cell Death Differ. 2009, 16 (11): 1445-1459. 10.1038\/cdd.2009.80.","journal-title":"Cell Death Differ"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2840-13-51.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:19:59Z","timestamp":1630552799000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/1475-2840-13-51"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,24]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["810"],"URL":"https:\/\/doi.org\/10.1186\/1475-2840-13-51","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,24]]},"assertion":[{"value":"4 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"51"}}